Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- Check3 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list, and the page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision from v3.4.2 to v3.4.3; no visible changes to study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page shows an updated revision label: Revision: v3.4.1 replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded UI options to Show glossary and Hide glossary, and updated non-substantive text labels including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision indicator (Revision: v3.4.0). Removed older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check68 days agoChange DetectedThe update is limited to revision metadata, changing from v3.3.3 to v3.3.4; there are no changes to core study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.